Gessain A, Mahieux R, de Thé G
Départment du SIDA et des Rétrovirus, Institut Pasteur, Paris, France.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S132-45. doi: 10.1097/00042560-199600001-00022.
In the past few years, numerous investigators have demonstrated that human T cell leukemia/lymphoma virus type I (HTLV-I) possesses a great genetic stability, and recent data indicate that viral amplification via clonal expansion of infected cells, rather than by reverse transcription, could explain this remarkable genetic stability. In parallel, the molecular epidemiology of HTLV-I proviruses showed that the few nucleotide changes observed between isolates were specific for the geographical origin of the patients but not for the type of the associated pathologies (adult T cell leukemia/lymphoma, tropical spastic paraparesis/HTLV-I-associated myelopathy). Thus, based on sequence and/or restriction fragment length polymorphism analysis of more than 250 HTLV-I isolates originating from the main viral endemic areas, three major molecular geographical subtypes (or genotypes) emerged, strongly supported by phylogenetic analysis (high bootstrap values). Each of these genotypes (Cosmopolitan, Central African, and Melanesian) appeared to arise from ancient interspecies transmission between monkeys infected with simian T cell leukemia/lymphoma virus type I and humans. Furthermore, careful sequences analyses indicate that, within (or alongside) these three main genotypes, there are molecular subgroups defined clearly by several specific mutations but not always supported by phylogenetic analyses. Thus in Japan, there is evidence for two ancestral HTLV-I lineages: the classical Cosmopolitan genotype, representing approximately 25% of the HTLV-I present in Japan and clustering in the southern islands; and a related subgroup that we called the Japanese group. Similarly, within the Central African cluster, there are molecular subgroups defined by specific substitutions in either the env or the long terminal repeat. Furthermore, recent data from our laboratory indicate the presence of a new molecular phylogenetic group (fourth genotype) found among inhabitants of Central Africa, particularly in Pygmies. While geographical subtypes vary from 2 to 8% between themselves, HTLV-I quasi-species present within an individual appear to be much lower, with a variability of < 0.5%.
在过去几年中,众多研究人员已证明,人类I型T细胞白血病/淋巴瘤病毒(HTLV-I)具有高度的遗传稳定性,近期数据表明,通过受感染细胞的克隆扩增而非逆转录进行病毒扩增,可以解释这种显著的遗传稳定性。与此同时,HTLV-I前病毒的分子流行病学显示,分离株之间观察到的少数核苷酸变化是患者地理来源所特有的,而非相关病理类型(成人T细胞白血病/淋巴瘤、热带痉挛性截瘫/HTLV-I相关脊髓病)所特有。因此,基于对来自主要病毒流行地区的250多个HTLV-I分离株的序列和/或限制性片段长度多态性分析,出现了三种主要的分子地理亚型(或基因型),系统发育分析(高自展值)对此提供了有力支持。这些基因型(世界型、中非型和美拉尼西亚型)中的每一种似乎都源自感染I型猿猴T细胞白血病/淋巴瘤病毒的猴子与人类之间古老的种间传播。此外,仔细的序列分析表明,在这三种主要基因型内部(或旁边),存在由几个特定突变明确界定的分子亚组,但并非总是得到系统发育分析的支持。因此,在日本,有证据表明存在两种祖传的HTLV-I谱系:经典的世界型基因型,约占日本境内HTLV-I的25%,聚集在南部岛屿;以及一个相关亚组,我们称之为日本组。同样,在中非簇内,存在由env或长末端重复序列中的特定替代所界定的分子亚组。此外,我们实验室最近的数据表明,在中非居民中,特别是在俾格米人中,发现了一个新的分子系统发育组(第四基因型)。虽然地理亚型之间的差异为2%至8%,但个体内存在的HTLV-I准种似乎要低得多,变异率<0.5%。